Facebook
Instagram
Linkedin
Twitter
Vimeo
Home
Single Company Reports
Investment Trust Centre
Market Reports & Share Ideas
Members
Events
News
Shares
Features
Commodities/FX
Private Equity & Venture Capital
Tax-Efficient Guides
Property
Podcasts
Video
Awards
Account
Login
Become Member
Search
Facebook
Instagram
Linkedin
Twitter
Vimeo
Become Member
Login
Account
Search
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
Investment Trust Centre
Home
Premium
Reports
Single Company Reports
Market Reports & Share Ideas
Tax-Efficient Guides
News
Funds & Trusts
Commodities & FX
Private Equity & Venture Capital
Property
Politics
Shares
Features
Podcasts
Video
Events
Awards
- Advertisement -
Andrew Hore
twitter
Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.
Premium
Peter Gyllenhammar builds stake in First Property
IPO Analysis
New AIM admission: Big Technologies goes to huge premium
IPO Analysis
New standard listing: Spinnaker Acqusitions targets sustainable acquisition
Premium
Tip update: More than 40% rise in Hargreaves Services price in three months
IPO Analysis
New AIM admission: Northcoders set for training roll out
IPO Analysis
New AIM admission: GENinCode awaiting FDA approval
IPO Analysis
New AIM admission: Zenova’s fire retardant IP is not a flame proof investment
IPO Analysis
New standard listing: Sivota seeking Israeli technology deal
IPO Analysis
New AIM admission: Microlise Group
IPO Analysis
New AIM admission: Lords Group Trading
IPO Analysis
New AIM: Admission Revolution Beauty
IPO Analysis
New AIM admission: Bradda Head
IPO Analysis
New AIM admission: Poolbeg Pharma
IPO Analysis
All Active Asset bid approach for Audioboom
IPO Analysis
New standard listing: Acceler8 Ventures
IPO Analysis
New AIM admission: Forward Partners Group
IPO Analysis
New premium listing: Seraphine
IPO Analysis
New AIM admission: Orcadian Energy
IPO Analysis
New AIM admission: Lendinvest
Premium
Good Energy reiterates indicative bid rejection
Premium
Healthcare M&A prospects
Premium
Potential financials and property bids
Premium
Upgrades at Hotel Chocolat
Premium
Tip: Prosperous niche drugs strategy
Premium
Tip update: AdEPT Technology
IPO Analysis
New AIM admission: LungLife AI
IPO Analysis
New AIM admission: CMO Group
AQUIS
New Aquis admission: Helium Ventures
IPO Analysis
New standard listing: Wise
IPO Analysis
New AIM Admission: Saietta Group
Load more
Xpeng – the Tesla rival whose shares have rallied 315% in two months
23/11/2020
‘End of Austerity’ promise hashed out during PMQs
10/10/2018
Brexit: 5,000 City jobs could leave UK
10/10/2018
Advanced Oncotherapy shares soar after cancer treatment milestone
10/10/2018
Two reasons Travelodge backers can expect sleepless nights
24/07/2020